Editorial: The Role of Complement in Tumors

Front Immunol. 2020 Feb 11:11:139. doi: 10.3389/fimmu.2020.00139. eCollection 2020.

Authors

Barbara E Rolfe¹, Ruben Pio², Trent M Woodruff³, Maciej M Markiewski⁴, Helga D Manthey¹

Affiliations

¹ Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, Australia.
² Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
³ School of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.
⁴ Department of Immunotherapeutics and Biotechnology, School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, United States.

No abstract available

Keywords: C1q; C3a; C5a; C5b-9; cancer; complement; complement regulatory proteins; metastasis.

Publication types

Editorial
Introductory Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Complement Activation* / drug effects
Complement System Proteins / immunology*
Cytotoxicity, Immunologic
Humans
Immune Checkpoint Inhibitors / pharmacology
Immune Checkpoint Inhibitors / therapeutic use
Immunotherapy / methods
Molecular Targeted Therapy / methods
Neoplasms / drug therapy
Neoplasms / immunology*

Substances

Immune Checkpoint Inhibitors
Complement System Proteins

Grants and funding

R01 CA190209/CA/NCI NIH HHS/United States